Covid-19 Vaccine | Page 4 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
September 13, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, SEPTEMBER 13, 2025

Covid-19 Vaccine

Covid-19 Vaccine

Computer image of a betacoronavirus which is the type of virus linked to Covid-19

UK scientists find higher risk of brain clots from Covid-19 compared with vaccines

The researchers said in a pre-print study that the risk of CVST was 8-10 times higher following Covid-19 infection than it was from existing vaccines for the disease

FILE PHOTO: Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (Covid-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit Dave/File Photo

India to fast-track emergency-use approval for foreign-produced Covid vaccines

World Bank President David Malpass. Photo: Reuters

World Bank's Malpass says slow Covid-19 vaccine rollout in Europe is concerning

A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, US, May 18, 2020. Reuters/Brian Snyder/File Photo

US begins studying risk of allergic reactions to Moderna, Pfizer Covid-19 vaccines

Photo: Collected

First Covid vaccine shot alone not protective: Chile study

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" are placed on dry ice in this illustration taken, December 4, 2020. Picture taken December 4, 2020. REUTERS/Dado Ruvic/File Photo

CanSinoBIO says Covid-19 shot may be less effective over time, booster shot promising

The production of line for vials of Covishield at the Serum Institute of India Ltd. Hadaspar plant in Pune, India, on Jan. 22. Photographer: Dhiraj Singh/Bloomberg

Covax expects full vaccine supplies from India's Serum in May, says Unicef

FILE PHOTO: Eswar Jani, 31, a sanitation worker, receives COVISHIELD, a Covid-19 vaccine manufactured by Serum Institute of India, during the world's largest Covid-19 vaccination campaigns at Mathalput Community Health Centre in the remote Koraput district of the eastern state of Odisha, India, January 16, 2021. REUTERS/Danish Siddiqui

Indian state warns of vaccine shortage, immunisations hit record

It’s more than a fear of needles. Photo: Ezra Acayan/Getty via Bloomberg

How do we conquer vaccine skeptics? We listen

Photo: Collected

UK expects EU to stand by its vaccine commitment, says PM's spokesman

Women wearing protective face masks walk amid the rush of people along a road as the outbreak of the coronavirus disease (COVID-19) continues, in Karachi, Pakistan July 20, 2020. Photo: Reuters

Pakistan receives 500,000 vaccine doses from China, doubling available supply

AstraZeneca said its vaccine shows no evidence of increased risk of blood clots.

No evidence of increased blood clot risk from vaccine, says AstraZeneca

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

Canada clears Johnson & Johnson vaccine, first to approve 4

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net